|
National Stock Number(NSN): 6505-01-457-8137 (6505014578137, 014578137)
| NIIN: |
01-457-8137 |
Item Name: |
ERGOTAMINE TARTRATE AND CAFFEINE TABLETS |
INC: |
34182
|
| FSC: |
6505
|
Assignment Date: |
Aug-04-1998 |
CRIT: |
X |
IIG: |
34182 |
| ISC: |
5 |
Date Standardized: |
Aug-04-1998 |
HMIC: |
P |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Apr-11-2023 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
A |
Schedule B: |
3004.49.0070 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
0 |
RPDMRC: |
6 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
0682161 |
B6095
|
ASSOCIATION PHARMACEUTIQUE BELGE-ALGEMENE PHARMACEUTISCHE BOND |
H |
6 |
9 |
9 |
ZB |
4 |
B |
|
|
|
|
|
1246081 |
B6095
|
ASSOCIATION PHARMACEUTIQUE BELGE-ALGEMENE PHARMACEUTISCHE BOND |
H |
6 |
9 |
9 |
ZB |
4 |
B |
|
|
|
|
|
CAFERGOT 2MG 5 ZETPILLEN |
B1049
|
NOVARTIS PHARMA |
H |
5 |
2 |
4 |
ZB |
4 |
D |
|
|
|
|
|
CAFERGOT SUPP. 5X2MG |
B1049
|
NOVARTIS PHARMA |
H |
5 |
2 |
4 |
ZB |
4 |
D |
|
|
|
|
|
CAFERGOT5SUPPO |
04549
|
SANDOZ INC |
H |
3 |
2 |
4 |
9Z |
4 |
A |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 MILLIGRAMS ERGOTAMINE TARTRATE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS CAFFEINE ACTIVE INGREDIENT |
| FEAT |
SPECIAL FEATURES |
USED IN TREATING MIGRAINE HEADACHES; SYMPATHOLYTIC DRUG; ADMINISTERED IN SUPPOSITORY FORM; 5 SUPPOSITORIES PR PKG; 1 SUPP PR WRAPPER; NON HABIT FORMING; CONSTRICTS BLOOD VESSELS IN HEAD; STIMULATES CENTRAL NERVOUS SYSTEM; NOT INTENDED FOR PROLONGED USE; DISCONTINUE GRADUALLY IF USING THIS DRUG 1 MONTH OR MORE; MAY CAUSE WITHDRAWAL SYMPTOMS SUCH AS HEADACHE, DROWSINESS, IRRITABILITY |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| ZB01 |
|
Aug-04-1998 |
|
|
|
|
ZB |
ZB |
|